Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Current Leases (2021 - 2025)

Historic Current Leases for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to $1.2 million.

  • Pliant Therapeutics' Current Leases rose 26863.35% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 26863.35%. This contributed to the annual value of $542000.0 for FY2024, which is 5887.71% down from last year.
  • According to the latest figures from Q3 2025, Pliant Therapeutics' Current Leases is $1.2 million, which was up 26863.35% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Pliant Therapeutics' Current Leases registered a high of $2.6 million during Q3 2022, and its lowest value of $98000.0 during Q2 2024.
  • Over the past 5 years, Pliant Therapeutics' median Current Leases value was $1.6 million (recorded in 2021), while the average stood at $1.5 million.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 9560.93% in 2024, then skyrocketed by 115000.0% in 2025.
  • Quarter analysis of 5 years shows Pliant Therapeutics' Current Leases stood at $1.9 million in 2021, then skyrocketed by 31.46% to $2.5 million in 2022, then tumbled by 46.36% to $1.3 million in 2023, then crashed by 58.88% to $542000.0 in 2024, then soared by 119.0% to $1.2 million in 2025.
  • Its Current Leases stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $771000.0 for Q1 2025.